In an article in this journal, Logan et al.1 help to inform a piece of the outcomes prediction puzzle as they report on the potential link between a composite of physiologic markers in the neonate in the first 12 h of life (score for neonatal acute physiology II (SNAP-II)) and multifaceted neuropscyhosocial outcomes at 10 years of age in the Extremely Low Gestational Age Newborn (ELGAN) study.1 The ELGAN study represents a prospective multicenter group of infants born at <28 weeks between the years 2002 to 2004, with prospectively planned neurodevelopmental assessments at multiple time points.2 With the original sample size of 1506, the investigators were able to assess nearly 900 children at 10 years of age.1 This remarkable cohort has helped to inform some of our understanding of the pathophysiology associated with brain injury in ELGANs, as well as provide insight into the long-term outcomes, which are often lacking in clinical trials. Not surprisingly, the authors found that a high SNAP-II score in the first 12 h of life is associated with an increased risk of neurodevelopmental and social issues at 10 years of age.1 The authors offer one of the four possible explanations for their findings. The first two describe that physiologic derangements early in life are on the causal pathway to brain injury, as well as other preterm morbidities (for example, sepsis, chronic lung disease (CLD), and so on), and are thus predictors of neurodevelopment. The third explanation builds on the idea behind SNAP’s development, which involves additional factors besides gestational age and birth weight, and perhaps the SNAP score depicts a more accurate picture of the infant. The fourth involves the role inflammation on the early neonatal physiology and path to brain injury.
One of the biggest challenges for Neonatal Intensive Care Unit (NICU) providers is to help inform families regarding the outcomes of their infants. A big part of that conversation is devoted to the periviable antenatal counseling, where prior to birth, a decision is often asked to be made regarding intensive care versus comfort measures. Once past that decision point (or in situations where palliative care is not an option), parents and NICU staff both find themselves yearning for information that will help predict the outcomes of their baby for the days, months, years and decades to come.
Among the different prediction tools for neonates,3, 4, 5, 6 one of the earliest that expanded beyond gestational age and birth weight was the SNAP score.6 It was developed by Richardson et al.6 as a potential risk adjustor for outcomes across centers, where it was noted that markers such as birth weight and gestational age alone were inadequate to describing the full story. While the SNAP score correlates well with mortality, nursing workload and length of stay, the complexity due to the large number of data elements led the investigator group to develop more user friendly versions, such as SNAP-II and SNAP-perinatal extension.7
These observations by Logan et al.1 are informative and help build on the ELGAN study investigators’ previous work looking at the association between versions of the SNAP score and mortality,8 and brain injury in the NICU/neurodevelopment at 2 years of age.9 While all three SNAP studies in the ELGAN cohort perform a multivariate analysis adjusting for multiple confounders, the further one gets from the event (that is, the first 12 to 24 h of birth), the more challenging it is to make the link along the causal pathway between the predictor (SNAP-II) and outcomes, which the authors acknowledge as a limitation.
The authors add to the literature the importance of using a powerful risk adjustor such as SNAP or one of its derivatives as the impact is felt well beyond NICU mortality. In addition, it further emphasizes the importance of the critical time period after birth, including the first hour, or so called ‘golden hour’.10 Furthermore, it provides the NICU providers with data on a modern cohort of very small and very premature babies, which can be used to help with shared decision-making and information provided to families. The need for this predictive information is used to help inform families and identify potential modifiable targets that can then be used to develop therapies to mitigate some of the harm.
There is likely an additional component from information we seek as providers (consciously or subconsciously): we need reassurance that we are doing the right thing for a critically ill neonate (that is, avoiding futile care, pain and suffering for both the child and their family). Starting with the delivery room, the ‘wait and see’ approach to what a periviable neonate looks like before deciding on resuscitation has been shown to be misleading,11 and is frankly a moving target as resuscitation has shifted toward a younger gestational age over time. The attempt to inform the antenatal counseling using the National Institute of Child Health and Development calculator and four simple predictors (sex, antenatal steroids, gestational age and singleton birth)12 is appealing in its simplicity and desire to provide some tangible numeracy to the family. Yet, we know that the probability of an adverse neurodevelopmental outcome in a neonate is affected by morbidities during their NICU course (for example, CLD, brain injury or severe retinopathy of prematurity).13 In addition, that trajectory is quite dynamic and can shift vastly (in either positive or negative direction) from the antenatal predictors through events occurring during the NICU stay.14 Finally, we also know that a number of infants will improve in their neurodevelopment with time. The cohort from the Caffeine for Apnea of Prematurity trial15 had the prevalence of combined mortality or morbidity reduced from 40% at 18 months corrected age to 23% at 5 years of age, when combining the caffeine and placebo group together, with similar improvement noted in both groups.
The aforementioned attempts to predict outcome, along with multiple other articles, try to account statistically for potential confounders such as clinical course and socioeconomic milieu. Yet, there are other intangibles, including potential interventions that the infants are exposed to post discharge (for example, early intervention), environmental toxins, and the underlying genetics and epigenetics that further modify outcomes and have yet to be fully incorporated into either risk adjustment or prediction models. Thus, while continuing to link predictors to outcomes for informative, risk adjustment and innovative purposes are critical, we must continue to recognize the dynamic trajectory of a neonate through to adulthood. Both NICU providers and families should use caution when asking and answering the question ‘what does _____ mean for my child’, and acknowledge the unknown in either positive or negative direction.
References
Logan JW, Dammann O, Allred EN, Dammann C, Beam K, Joseph RM et al. Early postnatal illness severity scores predict neurodevelopmental impairments at 10 years of age in children born extremely preterm. J Perinatol 2017 (this issue).
O'Shea TM, Allred EN, Dammann O, Hirtz D, Kuban KC, Paneth N et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev 2009; 85 (11): 719–725.
Broughton SJ, Berry A, Jacobe S, Cheeseman P, Tarnow-Mordi WO, Greenough A . The mortality index for neonatal transportation score: a new mortality prediction model for retrieved neonates. Pediatrics 2004; 114 (4): e424–e428.
Lee SK, Zupancic JA, Pendray M, Thiessen P, Schmidt B, Whyte R et al. Transport risk index of physiologic stability: a practical system for assessing infant transport care. J Pediatr 2001; 139 (2): 220–226.
Parry G, Tucker J, Tarnow-Mordi W, CRIB II . An update of the clinical risk index for babies score. Lancet 2003; 361 (9371): 1789–1791.
Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA . Score for neonatal acute physiology: a physiologic severity index for neonatal intensivecare. Pediatrics 1993; 91 (3): 617–623.
Richardson DK, Corcoran JD, Escobar GJ, Lee SK . SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001; 138 (1): 92–100.
Dammann O, Shah B, Naples M, Bednarek F, Zupancic J, Allred EN et al. Interinstitutional variation in prediction of death by SNAP-II and SNAPPE-II among extremely preterm infants. Pediatrics 2009; 124 (5): e1001–e1006.
Dammann O, Naples M, Bednarek F, Shah B, Kuban KC, O’Shea TM et al. SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in extremely low gestational age newborns: the ELGAN study. Neonatology 2010; 97 (2): 71–82.
Wyckoff MH . Initial resuscitation and stabilization of the periviable neonate: the Golden-Hour approach. Semin Perinatol 2014; 38 (1): 12–16.
Singh J, Fanaroff J, Andrews B, Caldarelli L, Lagatta J, Plesha-Troyke S et al. Resuscitation in the "gray zone" of viability: determining physician preferences and predicting infant outcomes. Pediatrics 2007; 120 (3): 519–526.
Tyson JE, Parikh NA, Langer J, Green C, Higgins RD . Intensive care for extreme prematurity—moving beyond gestational age. N Engl J Med 2008; 358 (16): 1672–1681.
Schmidt B, Roberts RS, Davis PG, Doyle LW, Asztalos EV, Opie G et al. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J Pediatr 2015; 167 (5): 982–6 e2.
Ambalavanan N, Carlo WA, Tyson JE, Langer JC, Walsh MC, Parikh NA et al. Outcome trajectories in extremely preterm infants. Pediatrics 2012; 130 (1): e115–e125.
Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307 (3): 275–282.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Dukhovny, D. ‘Does ________ predict neurodevelopmental impairment in former preterm infants?’ Is this the right question to be asked?. J Perinatol 37, 467–468 (2017). https://doi.org/10.1038/jp.2017.19
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2017.19